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Human lymphocyte yrosine protein kinases (TPKs) have been analyzed by gel-filtration chromatography. 
The major TPK species with activity towards an exogenous tyrosine-containing peptide had molecular 
masses of 70-100 kDa (TPK I) and 35-40 kDa (TPK II). TPKs I and II were distinct from the well-charac- 
terized autophosphorylating lymphoid cell TPK, pp56 lck [(1983) J. Biol. Chem. 258, 10738-10742]. Both 
TPK I and TPK II were down-regulated following mitogenic stimulation of lymphocytes with phytohae- 
magglutinin. By contrast, pp561ok remained clearly detectable in stimulated lymphocytes. We suggest that 
TPKs I and II may play a role in the regulation of the lymphocyte c ll cycle. 
Tyrosine protein kinase; Lymphocyte mitogenesis 
1. INTRODUCTION 
TPK activity was originally discovered in the 
products of viral oncogenes, but is now implicated 
in the control of normal as well as malignant cell 
proliferation [1]. The receptors for several growth 
factors and hormones, including platelet-derived 
and epidermal growth factors and insulin, are 
TPKs whose activity is regulated by the binding of 
their respective ligands [1]. However, little is 
known of the pathways linking changes in mem- 
brane TPK activity to changes in cell behaviour. 
Peripheral blood lymphocytes have a high level 
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of TPK activity [2,3], which decreases following 
mitogenic activation by the lectin phytohaemag- 
glutinin (PHA) [4], a polyclonal mitogen which 
binds the T cell antigen-receptor complex [5,6]. 
Although the known components of the receptor 
are not TPKs, mitogenic stimulation of murine [7] 
or human [8,9] T cells causes rapid tyrosine 
phosphorylation of specific proteins. 
The enzymes responsible for mitogen-stimulated 
tyrosine phosphorylation in lymphocytes have not 
been identified. The major autophosphorylating 
kinase, pp56 ~ck, a lymphocyte-specific protein 
closely related to pp60 c-src, has been extensively 
studied [10-13] and its cDNA has been cloned and 
sequenced [14]. Recently 35 and 40 kDa TPKs 
from rat spleen [15] and a 40 kDa soluble TPK 
from bovine thymus [16] have been partially or 
completely purified, but it has not been established 
whether they bear any relationship to pp56 lck or 
play a role in the transduction of mitotic signals. 
We therefore attempted to identify the T lym- 
phocyte TPKs whose activities vary during the 
PHA-stimulated cell cycle. We show that two 
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highly labile TPKs of 70-100 and 35-40 kDa 
respectively, detected by their ability to 
phosphorylate a synthetic tyrosine-containing pep- 
tide [11], are the major TPKs in lymphocyte par- 
ticulate fractions and are distinct from pp56 ~ck. 
Both these enzymes are almost completely down- 
regulated when resting cells are stimulated to enter 
the cell cycle. By contrast, we could not detect a 
change in the level of pp56 lek. 
2. MATERIALS AND METHODS 
2.1. Lymphocyte isolation and culture 
Lymphocytes were isolated from the blood of 
healthy volunteers by sedimentation  a Lym- 
phoprep gradient (Nyegaard, Oslo) and were freed 
of platelets and monocytes [4,8]. The cells were 
either lysed immediately or cultured at 37°C for 
72 h with 1 °70 PHA (Wellcome, Beckenham) at106 
cells/ml in RPMI medium (Gibco) containing 8070 
fetal calf serum and antibiotics. 
2.2. Enzyme extraction 
Preparation of the particulate fraction was car- 
ried out as in [4] except hat 1 mM PMSF and 1 °70 
aprotinin were included in all stages. TPK activity 
was extracted with 10 mM glycine-NaOH, pH 9.1, 
1 mM EDTA, 20 mM NaC1, 1°70 Triton X-100, 
30O7o glycerol, 20% sucrose, 5 mM 2-mercapto- 
ethanol, 1 mM PMSF and 1 0/0 aprotinin. 80°70 of 
the particulate TPK activity was solubilized in this 
manner. 
Zn2÷-dependent phosphatases were removed 
from the protein extract by affinity chromatogra- 
phy with Zn2÷-bound aminodiacetic acid Se- 
pharose 6B [17]. The resulting solution was applied 
to an FPLC Superose 12 gel-filtration column 
(Pharmacia) and eluted at a rate of 0.3 ml/min 
with 20 mM Tris-Cl (pH 8), 1 mM EDTA, 20 mM 
NaCI, 200/0 glycerol (w/v), 1 o70 Triton X-100 (w/v) 
and 5 mM 2-mercaptoethanol. Fractions of 0.5ml 
were collected and 1 mg/ml BSA was added im- 
mediately to stabilize the highly labile TPK ac- 
tivity. 
2.3. Enzyme assays 
TPK activity was quantitated [4] by measuring 
the incorporation of label from [7-32p]ATP into 
the synthetic peptide RRsrc [11]. Autophospho- 
rylation reactions were carried out by incubation 
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of enzyme fractions with [7,-32P]ATP in the 
absence of exogenous substrates. Proteins phos- 
phorylated on tyrosine residues were identified by 
analysis of reaction mixtures on 8.5% polyacryl- 
amide gels followed by hydrolysis in 1 N KOH and 
autoradiography [3,4]. 
3. RESULTS 
3.1. Chromatographic resolution of  TPKs in 
resting lymphocytes 
Extracts of particulate fractions from resting T 
lymphocytes were freed from ZnE+-dependent 
tyrosine protein phosphatases by affinity 
chromatography and then fractionated by gel 
filtration and the fractions assayed for TPK activi- 
ty using RRsrc as substrate. Two major peaks were 
detected, with apparent molecular masses in the 
range 70-100 kDa (TPK I) and 30-40 kDa (TPK 
II) (fig.l, open triangles). TPK I showed an ap- 
parent Km for RRsrc of 0.77 mM and TPK II a Km 
of 1.56 mM. The apparent Km values for ATP 
were 80 and 16/zM, respectively, for TPK I and II 
(not shown). Attempts at further purification and 
characterisation of TPKs I and II have been 
hindered by the rapid loss of activity on storage or 
further chromatography. T lymphocyte TPK II 
has a similar molecular mass to the 40 kDa TPK 
isolated from bovine thymus [16], and both en- 
zymes are extremely labile suggesting that they 
may be related. However, the thymus TPK is a 
soluble enzyme where TPK II is particulate. 
3.2. Relationship of TPKs I and H to pp56 tc~ 
pp56 lck is readily detected in particulate frac- 
tions of lymphocytes by its ability to 
autophosphorylate on tyrosine residues [10-13]. 
We therefore assayed the Superose 12 fractions for 
pp56 lck by incubating them with [7-32p]ATP. Pro- 
teins phosphorylated on tyrosine residues were 
detected by gel electrophoresis, followed by in- 
cubation of the gel in alkali in order to eliminate 
phosphate sterified on serine residues. We have 
established by acid hydrolysis followed by elec- 
trophoretic analysis that autophosphorylating lym- 
phocyte proteins detected in this manner are 
predominantly phosphorylated on tyrosine 
residues [3,4]. pp56 lck eluted between 12 and 13 ml 
(fig.2). Comparison with fig.l shows that pp56 lck 
eluted between the peaks of TPK I and II strongly 
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Fig.l. Superose 12 elution profile of solubilized 
particulate TPK activity from untreated (zx---zx) and 
PHA treated (-" -') lymphocytes. The activity shown 
is the rate of 32po4 incorporation i to RRsrc per mg 
protein loaded. Each point represents the average of 
duplicate assays. The unbroken line is a typical protein 
elution profile. A similar pattern was obtained for both 
PHA-treated and untreated lymphocytes. Arrows 
indicate elution positions of molecular weight markers: 
A, bovine serum albumin, 67 kDa; B, ovalbumin, 
43 kDa; C, chymotrypsinogen, 25 kDa. 
suggested that this enzyme, detected by its ability 
to autophosphorylate, was a separate ntity from 
the two TPKs detected by their ability to 
phosphorylate an exogenous tyrosine-containing 
peptide. The pp56 lck of normal lymphocytes ap- 
peared to have a relatively low reactivity towards 
RRsrc. 
No tyrosine-phosphorylated protein band cor- 
responding to TPK I was detected (fig.2, lanes 
2,3), suggesting that this enzyme either did not 
autophosphorylate or did so at a level too low to 
be detectable. A number of phosphorylated pro- 
tein bands were seen in the fractions corresponding 
to TPK II. However, we cannot at present be cer- 
tain whether any of these bands corresponds to 
autophosphorylated TPK II, due to the promiscui- 
ty of TPKs in the phosphorylation of protein 
substrates. 
3.3. TPK I and H are down-regulated following 
PHA stimulation of lymphocytes 
Extracts of particulate fractions prepared from 
lymphocytes 3 days following PHA-stimulated 
mitogenesis were analyzed by Superose 12 column 
chromatography. Assay of the column fractions 
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Fig.2. In vitro autophosphorylation f Superose 12 
column fractions from untreated lymphocyte particulate 
fraction separated by SDS-PAGE (see section 2 for 
details). Arrows on the left indicate molecular masses, 
those on the right denote apparent molecular masses of 
labelled proteins. The peak fractions for TPK I and II 
are indicated. 
with RRsrc showed that both TPK I and II were 
almost undetectable (fig. 1, solid triangles). By con- 
trast, pp56 ~ck, revealed by autophosphorylation, 
was readily detectable (fig.3) at intensities com- 
parable to those in fractions from resting lym- 
phocytes (fig.2). Therefore, we conclude that both 
TPK I and TPK II were down-regulated following 
mitotic stimulation of T lymphocytes whereas 
pp56 ~ck was unaffected. This latter conclusion is in 
agreement with our previous observations on 
pp56 ~¢k autophosphorylation i unfractionated 
lymphocyte particulate preparations [4]. We stress 
that the down-regulation of TPK I and II was 
strictly a consequence of PHA stimulation, since 
incubation of lymphocytes in culture medium for 
3 days resulted in an increase in particulate TPK 
activity [4]. In addition, down-regulation of par- 
ticulate TPK following PHA treatment is not due 
to translocation of the enzyme to another cellular 
compartment [4]. Assays of the Superose column 
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Fig.3. In vitro autophosphorylation of Superose 12 
column fractions from PHA treated lymphocyte 
particulate fractions (see legend to fig.2for details). 
fractions howed that the observed ecrease in ac- 
tivity of TPK I and II could not be explained by an 
increase in either ATPase or phosphatase activity, 
which could potentially have interfered with the 
TPK assay (not shown). 
4. DISCUSSION 
Growing evidence suggests that the phospho- 
rylation of proteins on tyrosine residues contri- 
butes to the process of mitotic signal transduction 
in T lymphocytes [7-9]. We therefore attempted to 
identify TPK species in lymphocytes whose activity 
varied during the cell cycle. Following gel filtration 
of cell extracts we have identified two peaks of 
TPK activity, TPK I and II, which eluted in dif- 
ferent fractions from the well-characterized 
pp56 ]ck [10-14]. 
Clarification of the relationship between TPK I 
and II and their biochemical characterization have 
been frustrated by the extreme lability and low 
yield of these activities, which are lost completely 
on overnight storage. However, we have observed 
a 2-fold difference in their apparent Arm values 
towards RRsrc and a 5-fold difference in the Km 
towards ATP. However, we cannot conclude that 
they are distinct species, since TPK I may be a 
dimer of TPK II, with consequently altered kinetic 
parameters. It is unlikely that TPK II is a pro- 
teolytic degradation product of TPK I, since pro- 
tease inhibitors were used during enzyme 
extraction. 
TPKs I and II were down-regulated following 
mitotic stimulation of lymphocytes, whereas 
pp56 lck was not. pp56 lck is a member of a closely 
related family of TPKs which have strong sequence 
homology to c-src, the cellular homologue of the 
transforming gene of Rous sarcoma virus 
[14,18,19]. The expression of several members of 
this TPK family (c-src, hck) in post-mitotic eils 
has led to the suggestion that these may be in- 
volved in maintenance of the differentiated state of 
ceils rather than in mitotic signalling [18,19]. 
Given the strong sequence homology of pp56 ]ck the 
products of c-src and hck [14,18,19] and the in- 
variance of pp56 ~ck during the lymphocyte cell 
cycle, we suggest that pp56 ~ck may also be involved 
in maintaining the differentiated state of lym- 
phocytes rather than in the control of pro- 
liferation. 
By contrast, the down-regulation f TPK I and 
II following mitotic activation is reminiscent of the 
loss of the TPK-containing receptors for EGF [20] 
and PDGF [21] following stimulation with the ap- 
propriate growth factor. Ligand-stimulated down- 
regulation is not of itself proof of involvement of 
TPK in regulation of the cell proliferation. 
However, taken with the evidence for involvement 
of tyrosine phosphorylation in lymphocyte mitotic 
signalling [7-9], down-regulation f TPK I and II 
prompts us to suggest that they may be candidates 
for a role in transduction of the PHA signal. We 
note, however, that lymphocyte TPK activity is 
lost between 24 and 48 h following activation of T 
lymphocytes [4], whereas the EGF and PDGF 
receptors are lost within hours of mitogen stimula- 
tion of fibroblasts [20,21]. However, the G1 phase 
of the lymphocyte has a duration of 1-2 days, 
whereas that of fibroblasts is only several hours 
long. Therefore, the longer half-life for down- 
regulation of lymphocyte TPK [4] may be related 
to the extended time scale of pre-replicative events 
in these ceils. 
By contrast with the receptors for EGF and 
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PDGF, which include intrinsic ligand-stimulated 
TPK activity [1], TPKs I and II are not an integral 
part of the known components of the T cell recep- 
tor or its associated CD3 complex, since the 
cytoplasmic domains of these proteins are too 
small to include an enzymic activity [22]. Mitogen 
stimulation of T lymphocytes triggers rapid 
breakdown of inositol-containing lipids [23] and 
the consequent generation of diacylglycerol [24] 
activates the serine/threonine-specific protein 
kinase C, which is rapidly translocated from the 
cytosol to the membrane fraction [25,26]. Further- 
more, tyrosine phosphorylation of the same 
42 kDa protein is elicited both by PHA or TPA 
treatment of lymphocytes [8]. Since TPA activates 
kinase C directly [24], we reasoned that ctivation 
of lymphocyte TPKs by PHA occurs indirectly as 
a consequence of inositol ipid breakdown and ac- 
tivation of kinase C [8]. Clarification of the details 
of this pathway are the subject of continuing in- 
vestigations. 
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